ISTH0036: Clinical Trials

1 trial of ISTH0036, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow ISTH0036: new trials by email Literature Review of ISTH0036 trials Research Report on ISTH0036

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy
TGF-β2 antisense oligonucleotide, Trabeculectomy - Primary Open Angle Glaucoma
Phase 1CompletedIsarna Therapeutics GmbH132015-04-012018-02-28

Conditions studied

Glaucoma (1)  ·  Glaucoma, Open-Angle (1)

Sponsors

Isarna Therapeutics GmbH (1)

Countries

Germany (1)

Top investigators

Petra Fettes, PhD (1)

NIH funding

2014 (1)